ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 145 filers reported holding ARGENX SE in Q1 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,676,760 | +1629.0% | 12,000 | +1580.7% | 0.69% | +3744.4% |
| Q4 2022 | $270,485 | -50.8% | 714 | -54.2% | 0.02% | -75.3% |
| Q3 2022 | $550,000 | -17.3% | 1,559 | -11.2% | 0.07% | +12.3% |
| Q2 2022 | $665,000 | +2.6% | 1,756 | -18.1% | 0.06% | -9.7% |
| Q3 2021 | $648,000 | +175.7% | 2,145 | +174.6% | 0.07% | +176.9% |
| Q2 2021 | $235,000 | -11.7% | 781 | -22.9% | 0.03% | -7.1% |
| Q3 2020 | $266,000 | +4.3% | 1,013 | -47.8% | 0.03% | -40.4% |
| Q1 2020 | $255,000 | – | 1,939 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |